1-3 of 3
Maria del Pilar Martinez
Close
Sort by
Journal Articles

Different Prognosis According to Subtype-Oriented Protocols in Elderly Patients with Acute Lymphoblastic Leukemia (ALL). Comparison of Three Prospective Parallel Trials from the Pethema Group

Josep-Maria Ribera, MD, PhD, Olga Garcia, Pascual Fernandez, Pau Montesinos, Salut Brunet, Maria del Pilar Martinez, Esperanza Lavilla, Teresa Bernal, MD, Jose González, MD, PhD, Mar Tormo, MD, Pere Barba, Carmen Monteserín, Josep Sarrá, MD, Marta Fernandez, Mercedes Colorado, Andrés Novo, Antonio Garcia, Maria Calbacho, Eugenia Abella, Maria-Jose Moreno, Jesús-Maria Hernández-Rivas, MD, PhD, Maria-Elsa Lopez, Natalia Alonso, Alfons Serrano, Evarist Feliu, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3869.
https://doi.org/10.1182/blood.V122.21.3869.3869
Published: 2013
Journal Articles

FLT3, PIM and CXCR4 Expression In Acute Myeloid Leukemia

Rafael Alonso Fernández, Inmaculada Rapado, MD, Castro Nerea, MD, Pilar Martinez-Sanchez, MD, Ascensión Peña, MD, Luis Garcia-Alonso, MD, Montserrat Rubio, MD, Antonia Rodriguez, MD, Maria del Pilar Martinez-Barranco, MD, Maria del Carmen Calle, MD, Maria Jose Otero, MD, Juan Carlos Ponce, Florinda Gilsanz-Rodriguez, Rosa M. Ayala, MD, PhD, Joaquin Martinez-Lopez, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4957.
https://doi.org/10.1182/blood.V122.21.4957.4957
Published: 2013
Journal Articles

Tat engagement of p38 MAP kinase and IRF7 pathways leads to activation of interferon-stimulated genes in antigen-presenting cells

Nayoung Kim, Sami Kukkonen, Maria Del Pilar Martinez-Viedma, Sumeet Gupta, Anna Aldovini
Journal: Blood
Blood (2013) 121 (20): 4090–4100.
https://doi.org/10.1182/blood-2012-10-461566
Published: 2013
Includes: Supplemental data